USA – Biogen is planning to lay off over 1000 employees following the disappointing launch of its Alzheimer’s therapy Aduhelm (aducanumab), according to STAT News. According to STAT News, Biogen…
Read MoreUSA – Biogen is planning to lay off over 1000 employees following the disappointing launch of its Alzheimer’s therapy Aduhelm (aducanumab), according to STAT News. According to STAT News, Biogen…
Read More